Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Gaičiūnas, , Gabrielius,
DOB:	19-MAY-1948 (Age: 77)
Gender:	male
Address:	5951 Monika Rapid 97190 Poškaton (Lithuania)
ID:	5711-320329-3 (ECI)

Report
Date:	09-OCT-2020

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Dr. Tomas Bakas 182 Savanorių pr. LT-91200 Klaipėda (Lithuania)

Specimen
Collected:	09-OCT-2020

Chemistry

Test	09-OCT-2020	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	4.0 L	4.6 - 6.4	%
Glucose [Mass/volume] in Blood	75.5	70 - 110	mg/dL
Urea nitrogen [Mass/volume] in Blood	17.1	7 - 43	mg/dL
Creatinine [Mass/volume] in Blood	0.8 L	0.9 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	8.8	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	143.7	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	4.6	3.5 - 5.3	mmol/L
Chloride [Moles/volume] in Blood	101.4	98 - 108	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	27.8	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	261.4 H	0 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	111.8	0 - 199	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	208.2 H	0 - 130	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	30.8 L	40 - 100	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows dyslipidemia with elevated total and LDL cholesterol and low HDL cholesterol, increasing cardiovascular risk. HbA1c is below normal, possibly reflecting hypoglycemia or recent changes in glucose metabolism, though current glucose is normal. Creatinine is slightly low but not clinically significant. Other parameters are within normal limits. Recommend further cardiovascular risk assessment and review of glycemic control.

Conclusion and Recommendations based on this report and previous findings known to us

The patient shows dyslipidemia with elevated total and LDL cholesterol and low HDL cholesterol, increasing cardiovascular risk. HbA1c is below normal, possibly reflecting hypoglycemia or recent changes in glucose metabolism, though current glucose is normal. Creatinine is slightly low but not clinically significant. Other parameters are within normal limits. Recommend further cardiovascular risk assessment and review of glycemic control.